Pancreatic cancer is rare compared to other cancers, but it accounts for a significant share of cancer deaths
Pancreatic cancer makes up roughly 3 percent of all new cancer diagnoses in the United States each year, but it causes about 7 percent of cancer deaths. This gap exists because pancreatic cancer is often found at a later stage, when it is harder to treat. In 2024, the American Cancer Society estimated that about 63,000 new cases would be diagnosed in the United States, with roughly 50,000 deaths from the disease.
The actual number of cases varies by year and by region. These figures come from cancer registries that track diagnoses across the country, so they represent observed cases rather than projections. The numbers have remained relatively stable over the past decade, though survival rates have improved slightly as treatment options have expanded.
Key Takeaways
- Pancreatic cancer represents about 3 percent of new cancer diagnoses but causes roughly 7 percent of cancer deaths because it is often diagnosed late.
- The United States sees approximately 63,000 new pancreatic cancer cases per year, though this number varies slightly from year to year.
- Risk increases with age, with most diagnoses occurring in people over 65, and men are diagnosed slightly more often than women.
- Smoking, chronic pancreatitis, diabetes, and family history are known risk factors, but most people with pancreatic cancer have no clear risk factor.
- Five-year survival rates have improved in recent years but remain lower than for many other cancers, largely because early detection is difficult.
Who gets pancreatic cancer and at what age
Pancreatic cancer is primarily a disease of older adults. The median age at diagnosis is 71, meaning half of all cases occur in people 71 or older. Cases in people under 50 are uncommon but do happen. Men are diagnosed slightly more often than women—roughly 55 percent of cases occur in men—though the reason for this difference is not fully understood.
Race and ethnicity also play a role in incidence rates. Black Americans have the highest incidence of pancreatic cancer among racial groups in the United States, followed by white Americans, Hispanic Americans, and Asian Americans. These differences may reflect variations in risk factors, screening practices, or access to healthcare, though research is ongoing to understand the full picture.
Risk factors that increase the chance of pancreatic cancer
Several factors are known to raise the risk of developing pancreatic cancer. Smoking is one of the strongest modifiable risk factors—smokers have roughly two to three times the risk of non-smokers. Chronic pancreatitis, a long-term inflammation of the pancreas, significantly increases risk. People with diabetes, particularly type 2 diabetes, also face higher risk, though the relationship is complex and not fully understood.
Family history matters as well. People with a parent, sibling, or child who had pancreatic cancer face higher risk than the general population. Inherited genetic mutations, such as BRCA1 and BRCA2 mutations, also raise risk. Obesity and heavy alcohol use are associated with increased risk, though the strength of these associations varies in research studies.
Having a risk factor does not mean a person will develop pancreatic cancer. Many people with risk factors never develop the disease, and many people diagnosed with pancreatic cancer have no identifiable risk factors at all.
Why pancreatic cancer is often diagnosed late
The pancreas sits deep in the abdomen, behind other organs, which makes early tumors difficult to detect by physical examination. Early pancreatic cancer typically causes no symptoms, or symptoms so mild that people do not seek medical care. By the time symptoms appear—such as abdominal pain, jaundice (yellowing of the skin and eyes), or unexplained weight loss—the cancer has often spread beyond the pancreas.
There is no routine screening test for pancreatic cancer in the general population, unlike mammography for breast cancer or colonoscopy for colorectal cancer. Screening is sometimes offered to people with strong family histories or known genetic mutations, but this is not standard practice. This lack of early detection tools is a major reason why pancreatic cancer has a lower survival rate than many other cancers.
Survival rates and how they have changed
The five-year survival rate for pancreatic cancer—the percentage of people who live at least five years after diagnosis—is approximately 12 percent overall in the United States. This is lower than for most other common cancers. However, survival varies significantly depending on the stage at diagnosis. People diagnosed with localized cancer (cancer confined to the pancreas) have a five-year survival rate around 40 percent, while those diagnosed with distant metastatic cancer (cancer that has spread to other organs) have a rate around 3 percent.
Survival rates have improved modestly over the past 15 years, from about 6 percent in the early 2000s to around 12 percent today. This improvement reflects advances in chemotherapy regimens, surgical techniques, and targeted therapies. Newer combination chemotherapy treatments have shown better outcomes than older single-drug approaches, particularly for advanced disease.
Geographic and demographic variations in pancreatic cancer rates
Pancreatic cancer rates vary across different regions of the United States, though the reasons are not always clear. Some variation reflects differences in the prevalence of risk factors like smoking and obesity. Other variation may relate to differences in how thoroughly cancer is diagnosed and reported in different areas, or differences in access to healthcare.
Internationally, pancreatic cancer rates are highest in developed countries, particularly in North America and Western Europe. Rates are lower in Asia, Africa, and South America, though this may partly reflect differences in cancer detection and reporting infrastructure rather than true differences in disease occurrence. As healthcare systems improve in developing countries, reported rates of pancreatic cancer have tended to increase.
How pancreatic cancer statistics are collected and what they mean
Pancreatic cancer statistics in the United States come primarily from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program, which collects data from cancer registries covering about 35 percent of the U.S. population. These registries record every new cancer diagnosis in their areas, creating a detailed picture of cancer occurrence. The American Cancer Society uses SEER data and other sources to produce annual estimates of new cases and deaths.
These statistics represent observed cases, not predictions. When you read that "about 63,000 new cases" are expected in a given year, this is based on historical trends and current population data, but the actual number may be higher or lower. Statistics also lag behind real time—data from 2024 may not be fully available until 2025 or 2026. Understanding this lag is important when reading recent news about cancer trends.
Frequently Asked Questions
Is pancreatic cancer becoming more common?
Overall incidence rates have remained relatively stable over the past 15 years. However, rates in younger adults have increased slightly in some studies, which researchers are still investigating. The reasons for this trend are not yet clear.
What is my personal risk of developing pancreatic cancer?
The average person's lifetime risk of developing pancreatic cancer is about 1 in 64. Your individual risk depends on your age, smoking status, family history, and other factors. A doctor can discuss your personal risk based on your specific situation.
Why do more people die from pancreatic cancer than are diagnosed with it each year?
This is not actually the case—more people are diagnosed than die each year. However, pancreatic cancer has a high mortality rate, meaning a large proportion of people diagnosed will die from it within five years. This is why the death rate is high relative to the number of new diagnoses.
Does having a family member with pancreatic cancer mean I will get it?
No. Family history raises your risk, but most people with a family history of pancreatic cancer never develop the disease. If you have multiple family members with pancreatic cancer or a known genetic mutation, talk with your doctor about whether screening or surveillance might be appropriate for you.
Are survival rates the same for everyone diagnosed with pancreatic cancer?
No. Survival varies widely based on stage at diagnosis, age, overall health, and how well the cancer responds to treatment. Survival rates also vary by race and ethnicity, which may reflect differences in access to treatment and other factors. Your doctor can discuss what the statistics mean for your specific situation.